Rankings
▼
Calendar
AVIR Q4 2019 Earnings — Atea Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AVIR
Atea Pharmaceuticals, Inc.
$484M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4,000
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-0.10
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$174,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$3M
Stockholders' Equity
$20M
Cash & Equivalents
$22M
← FY 2019
All Quarters
Q1 2020 →
